US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 1.300
  • +0.110+9.24%
Close Jan 3 16:00 ET
93.02MMarket Cap-4.39P/E (TTM)

Citius Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
Total revenue
0
0
0
Operating revenue
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
69.72%20.57M
149.58%12.12M
4.86M
Selling and administrative expenses
98.56%15.65M
451.59%7.88M
--1.43M
-General and administrative expense
98.56%15.65M
451.59%7.88M
--1.43M
Research and development costs
16.14%4.93M
23.71%4.24M
--3.43M
Operating profit
-69.72%-20.57M
-149.58%-12.12M
-4.86M
Net non-operating interest income expense
Other net income (expense)
Income before tax
-69.72%-20.57M
-149.58%-12.12M
-4.86M
Income tax
0.00%576K
0.00%576K
576K
Net income
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Net income continuous Operations
-66.56%-21.15M
-133.72%-12.7M
---5.43M
Minority interest income
Net income attributable to the parent company
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.56%-21.15M
-133.72%-12.7M
-5.43M
Basic earnings per share
-73.93%-0.31
-133.72%-0.1782
-0.0763
Diluted earnings per share
-73.93%-0.31
-133.72%-0.1782
-0.0763
Dividend per share
Currency Unit
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022
Total revenue 000
Operating revenue --0--0--0
Cost of revenue
Gross profit
Operating expense 69.72%20.57M149.58%12.12M4.86M
Selling and administrative expenses 98.56%15.65M451.59%7.88M--1.43M
-General and administrative expense 98.56%15.65M451.59%7.88M--1.43M
Research and development costs 16.14%4.93M23.71%4.24M--3.43M
Operating profit -69.72%-20.57M-149.58%-12.12M-4.86M
Net non-operating interest income expense
Other net income (expense)
Income before tax -69.72%-20.57M-149.58%-12.12M-4.86M
Income tax 0.00%576K0.00%576K576K
Net income -66.56%-21.15M-133.72%-12.7M-5.43M
Net income continuous Operations -66.56%-21.15M-133.72%-12.7M---5.43M
Minority interest income
Net income attributable to the parent company -66.56%-21.15M-133.72%-12.7M-5.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.56%-21.15M-133.72%-12.7M-5.43M
Basic earnings per share -73.93%-0.31-133.72%-0.1782-0.0763
Diluted earnings per share -73.93%-0.31-133.72%-0.1782-0.0763
Dividend per share
Currency Unit USDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes----
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.